ERYTECH PHARMA News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

02.03.17	ERYTECH Provides Business Update and Reports Financial Results for Full Year 2016 (Businesswire)
01.03.17	ERYTECH hält am 3. März 2017 eine Business-Update-Telefonkonferenz mit Erörterung der Finanzergebnisse 2016 ab (Businesswire)
17.01.17	ERYTECH präsentiert auf dem ASCO GI Symposium 2017 neue präklinische Daten zu ERY-MET (Businesswire)
17.01.17	ERYTECH Presents New Preclinical Data on ERY-MET at the 2017 ASCO GI Symposium (Businesswire)
06.12.16	Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital – November 2016 (Businesswire)
01.12.16	ERYTECH legt neue Daten zum Wirkmechanismus von GRASPA auf der ASH-Jahrestagung vor (Businesswire)
15.11.16	ERYTECH meldet Rückzug seines Antrags auf Marktzulassung in Europa für GRASPA bei akuter lymphatischer Leukämie und bereitet Wiedereinreichung vor (Businesswire)
14.11.16	ERYTECH Announces Withdrawal of Its European Marketing Authorization Application for GRASPA for Acute Lymphoblastic Leukemia and Prepares for Resubmission (Businesswire)
14.11.16	Erytech: Information related to total number of voting rights and shares composing the share capital – October 2016 (Businesswire)
03.11.16	ERYTECH Provides Business Update and Reports Financial Highlights for Third Quarter 2016 (Businesswire)
27.10.16	ERYTECH stärkt sein Executive Leadership Team durch Ernennungen eines neuen Chief Scientific Officer und eines neuen Chief Business Officer (Businesswire)
27.10.16	ERYTECH Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer (Businesswire)
27.10.16	ERYTECH hält am 4. November 2016 eine Business-Update-Telefonkonferenz zum 3. Quartal 2016 ab (Businesswire)
26.10.16	ERYTECH to Hold Q3 2016 Business Update Conference Call on November 4th, 2016 (Businesswire)
06.10.16	Erytech: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - September 2016 (Businesswire)
26.09.16	DGAP-News: ERYTECH PHARMA (EQS Group)
26.09.16	ERYTECH schliesst Aufnahme von Patienten in Phase-2-Studie zu Eryaspase (GRASPA®) bei Pankreaskrebs ab (Businesswire)
26.09.16	ERYTECH Completes Patient Enrollment in Phase 2 Trial of eryaspase (GRASPA®) for Pancreatic Cancer (Businesswire)
07.09.16	ERYTECH: Business Update und Finanzergebnisse für das erste Halbjahr 2016 (Businesswire)
06.09.16	ERYTECH Reports Business and Financial Update for the First Half of 2016 (Businesswire)
06.09.16	ERYTECH ernennt Allene M. Diaz zum neuen Mitglied seines Board of Directors (Businesswire)
06.09.16	ERYTECH ernennt Allene M. Diaz zum neuen Mitglied seines Board of Directors (Businesswire)
05.09.16	ERYTECH Appoints Allene M. Diaz to its Board of Directors (Businesswire)
01.09.16	Erytech : Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - August 2016 (Businesswire)
31.08.16	ERYTECH plant am 7. September 2016 Telefonkonferenz für Business-Updates des 2. Quartals 2016 (Businesswire)
30.08.16	ERYTECH to Hold Q2 2016 Business Update Conference Call on September 7th, 2016 (Businesswire)
29.08.16	ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia (Businesswire)
29.08.16	ERYTECH bringt Patientenaufnahme in Phase-2b-Studie zu Eryaspase (GRASPA®) bei akuter myeloischer Leukämie zum Abschluss (Businesswire)
02.08.16	Erytech: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - July 2016 (Businesswire)
11.07.16	Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - June 2016 (Businesswire)
07.06.16	Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - May 2016 (Businesswire)
11.05.16	ERYTECH meldet Höhepunkte der Geschäftsentwicklung und Finanzkennzahlen für das 1. Quartal 2016 (Businesswire)
10.05.16	ERYTECH Provides Business and Financial Highlights for First Quarter 2016 (Businesswire)
09.05.16	Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - April 2016 (Businesswire)
02.05.16	Erytech to Hold Q1 2016 Business Update Conference Call on May 11th, 2016 (Businesswire)
30.04.16	ERYTECH makes its 2015 Reference Document available (Businesswire)
07.04.16	Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital - March 2016 (Businesswire)
17.03.16	ERYTECH to Present Two Posters at AACR (Businesswire)
17.03.16	ERYTECH präsentiert zwei Poster auf der AACR-Jahrestagung (Businesswire)
16.03.16	ERYTECH erhält "Notice of Allowance" von US-Patent- und Markenamt für Patent zum Schutz seiner ERYCAPS-Immuntherapie-Technologie (Businesswire)
15.03.16	ERYTECH Receives USPTO Notice of Allowance for Patent Covering ERYCAPS Immunotherapy Technology (Businesswire)
09.03.16	Erytech Pharma: Information related to total number of voting rights and shares composing the share capital - February 2016 (Businesswire)
24.02.16	DGAP-News: ERYTECH PHARMA (EQS Group)
24.02.16	ERYTECH meldet Business Update und Finanzergebnisse für das Gesamtjahr 2015 (Businesswire)
23.02.16	ERYTECH Provides Business Update and Reports Financial Results for Full Year 2015 (Businesswire)
18.02.16	Erytech to Hold Full-year 2015 Business Update Conference Call on February 24, 2016 (Businesswire)
09.02.16	Erytech gibt seinen Finanzkalender für 2016 bekannt (Businesswire)
08.02.16	Erytech Announces 2016 Financial Calendar (Businesswire)
08.02.16	Erytech: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital January 2016 (Businesswire)
04.02.16	CORRECTING and REPLACING: Erytech Pharma: Information Related to Total Number of Voting Rights and Shares Composing the Share Capital (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Logitech Intl	74.06	1.20 %	K V
UBS Group	27.01	1.12 %	K V
Kuehne+Nagel Int	204.70	1.09 %	K V
Holcim	87.00	1.05 %	K V
Roche Hldg G	249.90	1.01 %	K V
Part Grp Hldg	1’213.50	0.21 %	K V
Lonza Grp	531.40	0.08 %	K V
Nestle	73.94	-0.05 %	K V
Sonova Hldg	295.20	-0.14 %	K V
Geberit	511.20	-0.58 %	K V

Nachrichten zu ERYTECH PHARMA

Aktien Top/Flop

Meistgelesene Nachrichten